Nephrocare Health Services Ltd.
•₹ 694.12.96%
2026-08-21
PROS
- Company is almost debt free
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 8.96x)
CONS
- Company is loss-making at the operating / net level
- Recent results are weak - TTM profit is down 37.2% versus prior year
- Company has a low return on equity of 2.4% over last 3 years
- Company has a low return on capital employed of 6.0%
- Interest coverage is weak at 0.9x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | NEPHROPLUS | 686.15 | 89.80 | 6899.86 | 0.00 | 31.97 | 28.57 | 281.75 | 28.54 | 16.18 | 21.41 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| 138 | 145 | 149 | 161 | 164 | 170 | |
| 116 | 123 | 145 | 138 | 142 | 160 | |
| Operating Profit | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — |
| Other Income | 4 | 3 | 3 | 3 | 6 | 6 |
| Interest | 3 | 4 | 3 | 4 | 1 | 0 |
| Depreciation | 12 | 13 | 12 | 13 | 16 | 13 |
| 11 | 7 | 7 | 9 | 11 | 17 | |
| Tax % | 24.84% | 23.45% | 27.31% | 5.69% | 1.00% | 24.74% |
| Net Profit | 8 | 6 | 5 | 8 | 11 | 13 |
| 1 | 1 | 0 | 1 | 1 | 0 | |
| Equity Capital | 2 | 2 | 4 | 20 | 20 | 20 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 2 | 2 | 4 | 20 | 20 | 20 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dec 2024
- 138
- 116
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 3
- Depreciation
- 12
- 11
- Tax %
- 24.84%
- Net Profit
- 8
- 1
- Equity Capital
- 2
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 2
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 145
- 123
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 4
- Depreciation
- 13
- 7
- Tax %
- 23.45%
- Net Profit
- 6
- 1
- Equity Capital
- 2
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 2
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 149
- 145
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 3
- Depreciation
- 12
- 7
- Tax %
- 27.31%
- Net Profit
- 5
- 0
- Equity Capital
- 4
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 4
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 161
- 138
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 4
- Depreciation
- 13
- 9
- Tax %
- 5.69%
- Net Profit
- 8
- 1
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 164
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 16
- 11
- Tax %
- 1.00%
- Net Profit
- 11
- 1
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 170
- 160
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 13
- 17
- Tax %
- 24.74%
- Net Profit
- 13
- 0
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| 386 | 436 | 544 | 630 | 644 | |
| 348 | 384 | 449 | 542 | 585 | |
| Operating Profit | 43 | 60 | 111 | 104 | — |
| OPM % | 11 | 14 | 20 | 16 | — |
| Other Income | 5 | 8 | 16 | 15 | 19 |
| Interest | 15 | 17 | 14 | 50 | 9 |
| Depreciation | 41 | 43 | 51 | 58 | 55 |
| -13 | 0 | 45 | -4 | 44 | |
| Tax % | -20 | -1,689 | 25 | -114 | 15 |
| Net Profit | -15 | 4 | 34 | -8 | 37 |
| EPS | -30 | 22 | 194 | -1 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -18 | 4 | 39 | -1 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -18 | 4 | 39 | -1 | — |
Mar 2023
- 386
- 348
- Operating Profit
- 43
- OPM %
- 11
- Other Income
- 5
- Interest
- 15
- Depreciation
- 41
- -13
- Tax %
- -20
- Net Profit
- -15
- EPS
- -30
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -18
Mar 2024
- 436
- 384
- Operating Profit
- 60
- OPM %
- 14
- Other Income
- 8
- Interest
- 17
- Depreciation
- 43
- 0
- Tax %
- -1,689
- Net Profit
- 4
- EPS
- 22
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2025
- 544
- 449
- Operating Profit
- 111
- OPM %
- 20
- Other Income
- 16
- Interest
- 14
- Depreciation
- 51
- 45
- Tax %
- 25
- Net Profit
- 34
- EPS
- 194
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
Mar 2026
- 630
- 542
- Operating Profit
- 104
- OPM %
- 16
- Other Income
- 15
- Interest
- 50
- Depreciation
- 58
- -4
- Tax %
- -114
- Net Profit
- -8
- EPS
- -1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
TTM
- 644
- 585
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 9
- Depreciation
- 55
- 44
- Tax %
- 15
- Net Profit
- 37
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 18%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 2%
- Last Year:
- -1%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| 2 | 2 | 2 | 20 | |
| 383 | 393 | 524 | 933 | |
| 115 | 93 | 60 | 2 | |
| Trade Payables | 14 | 41 | 61 | 85 |
| 115 | 115 | 92 | 67 | |
| Total Liabilities | 630 | 644 | 739 | 1,107 |
| ASSETS | - | - | - | - |
| 169 | 219 | 234 | 245 | |
| Capital Work in Progress | 0 | 1 | 4 | 4 |
| 148 | 149 | 212 | 335 | |
| 22 | 19 | 18 | 18 | |
| 0 | 138 | 194 | 218 | |
| Cash & Bank | 3 | 2 | 33 | 225 |
| 287 | 117 | 43 | 63 | |
| Total Assets | 630 | 644 | 739 | 1,107 |
| Total Debt | 196 | 178 | 123 | 3 |
| Net Working Capital | 126 | 72 | 176 | 492 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 2213.38 | 2255.24 | 2978.93 | 94.97 |
| Face Value | 10.00 | 10.00 | 10.00 | 2.00 |
| Total Debt | 196 | 178 | 123 | 3 |
| Net Working Capital | 126 | 72 | 176 | 492 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 2213.38 | 2255.24 | 2978.93 | 94.97 |
| Face Value | 10.00 | 10.00 | 10.00 | 2.00 |
Mar 2023
- 2
- 383
- 115
- Trade Payables
- 14
- 115
- Total Liabilities
- 630
- 169
- Capital Work in Progress
- 0
- 148
- 22
- 0
- Cash & Bank
- 3
- 287
- Total Assets
- 630
- Total Debt
- 196
- Net Working Capital
- 126
- Contingent Liabilities
- 0
- Book Value per Share
- 2213.38
- Face Value
- 10.00
- Total Debt
- 196
- Net Working Capital
- 126
- Contingent Liabilities
- 0
- Book Value per Share
- 2213.38
- Face Value
- 10.00
Mar 2024
- 2
- 393
- 93
- Trade Payables
- 41
- 115
- Total Liabilities
- 644
- 219
- Capital Work in Progress
- 1
- 149
- 19
- 138
- Cash & Bank
- 2
- 117
- Total Assets
- 644
- Total Debt
- 178
- Net Working Capital
- 72
- Contingent Liabilities
- 0
- Book Value per Share
- 2255.24
- Face Value
- 10.00
- Total Debt
- 178
- Net Working Capital
- 72
- Contingent Liabilities
- 0
- Book Value per Share
- 2255.24
- Face Value
- 10.00
Mar 2025
- 2
- 524
- 60
- Trade Payables
- 61
- 92
- Total Liabilities
- 739
- 234
- Capital Work in Progress
- 4
- 212
- 18
- 194
- Cash & Bank
- 33
- 43
- Total Assets
- 739
- Total Debt
- 123
- Net Working Capital
- 176
- Contingent Liabilities
- 0
- Book Value per Share
- 2978.93
- Face Value
- 10.00
- Total Debt
- 123
- Net Working Capital
- 176
- Contingent Liabilities
- 0
- Book Value per Share
- 2978.93
- Face Value
- 10.00
Mar 2026
- 20
- 933
- 2
- Trade Payables
- 85
- 67
- Total Liabilities
- 1,107
- 245
- Capital Work in Progress
- 4
- 335
- 18
- 218
- Cash & Bank
- 225
- 63
- Total Assets
- 1,107
- Total Debt
- 3
- Net Working Capital
- 492
- Contingent Liabilities
- 0
- Book Value per Share
- 94.97
- Face Value
- 2.00
- Total Debt
- 3
- Net Working Capital
- 492
- Contingent Liabilities
- 0
- Book Value per Share
- 94.97
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 11 | 57 | 80 | 133 | |
| Cash from Investing | -75 | -23 | -104 | -299 |
| Cash from Financing | 63 | -36 | 26 | 256 |
| -0 | -1 | 2 | 90 | |
| Free Cash Flow | 11 | -33 | 18 | 116 |
| OCF / Net Profit | -0.72 | 14.62 | 2.33 | -16.49 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -0.72 | 14.62 | 2.33 | -16.49 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2023
- 11
- Cash from Investing
- -75
- Cash from Financing
- 63
- -0
- Free Cash Flow
- 11
- OCF / Net Profit
- -0.72
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.72
- Cumulative 5-Year FCF
- 0
Mar 2024
- 57
- Cash from Investing
- -23
- Cash from Financing
- -36
- -1
- Free Cash Flow
- -33
- OCF / Net Profit
- 14.62
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 14.62
- Cumulative 5-Year FCF
- 0
Mar 2025
- 80
- Cash from Investing
- -104
- Cash from Financing
- 26
- 2
- Free Cash Flow
- 18
- OCF / Net Profit
- 2.33
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.33
- Cumulative 5-Year FCF
- 0
Mar 2026
- 133
- Cash from Investing
- -299
- Cash from Financing
- 256
- 90
- Free Cash Flow
- 116
- OCF / Net Profit
- -16.49
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -16.49
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | -88.89 | 22.20 | 193.97 | -0.80 |
| Book Value (₹) | 2213.38 | 2255.24 | 2978.93 | 94.97 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 29.24 | 53.30 | 96.42 | 4.94 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 11.15% | 11.91% | 17.45% | 14.00% |
| Net Margin % | -4.01% | 0.89% | 6.30% | -1.28% |
| ROE % | -4.02% | 1.00% | 7.44% | -1.09% |
| ROCE % | 0.36% | 2.90% | 9.56% | 5.61% |
| -2.46% | 0.61% | 4.95% | -0.87% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 122 | 112 | 111 | 119 |
| Inventory Days | 21 | 17 | 12 | 10 |
| Payable Days | 40 | 73 | 125 | 166 |
| 103 | 56 | -1 | -36 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.51x | 0.45x | 0.23x | 0.00x |
| Interest Coverage (x) | 0.14x | 1.01x | 4.17x | 0.92x |
| 1.80x | 1.39x | 2.14x | 4.27x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 12.98% | 24.61% | 15.85% |
| Operating Profit Growth % | 0.00% | 38.81% | 84.91% | -6.26% |
| Net Profit Growth % | 0.00% | 125.10% | 781.92% | -123.54% |
| 0.00% | 124.97% | 773.92% | -100.41% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 5.32x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 3.04x | 0.86x | 46.81x |
Mar 2023
- EPS (₹)
- -88.89
- Book Value (₹)
- 2213.38
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 29.24
- Operating Margin %
- 11.15%
- Net Margin %
- -4.01%
- ROE %
- -4.02%
- ROCE %
- 0.36%
- -2.46%
- Debtor Days
- 122
- Inventory Days
- 21
- Payable Days
- 40
- 103
- Debt to Equity (x)
- 0.51x
- Interest Coverage (x)
- 0.14x
- 1.80x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 22.20
- Book Value (₹)
- 2255.24
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 53.30
- Operating Margin %
- 11.91%
- Net Margin %
- 0.89%
- ROE %
- 1.00%
- ROCE %
- 2.90%
- 0.61%
- Debtor Days
- 112
- Inventory Days
- 17
- Payable Days
- 73
- 56
- Debt to Equity (x)
- 0.45x
- Interest Coverage (x)
- 1.01x
- 1.39x
- Revenue Growth %
- 12.98%
- Operating Profit Growth %
- 38.81%
- Net Profit Growth %
- 125.10%
- 124.97%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.04x
Mar 2025
- EPS (₹)
- 193.97
- Book Value (₹)
- 2978.93
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 96.42
- Operating Margin %
- 17.45%
- Net Margin %
- 6.30%
- ROE %
- 7.44%
- ROCE %
- 9.56%
- 4.95%
- Debtor Days
- 111
- Inventory Days
- 12
- Payable Days
- 125
- -1
- Debt to Equity (x)
- 0.23x
- Interest Coverage (x)
- 4.17x
- 2.14x
- Revenue Growth %
- 24.61%
- Operating Profit Growth %
- 84.91%
- Net Profit Growth %
- 781.92%
- 773.92%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.86x
Mar 2026
- EPS (₹)
- -0.80
- Book Value (₹)
- 94.97
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.94
- Operating Margin %
- 14.00%
- Net Margin %
- -1.28%
- ROE %
- -1.09%
- ROCE %
- 5.61%
- -0.87%
- Debtor Days
- 119
- Inventory Days
- 10
- Payable Days
- 166
- -36
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 0.92x
- 4.27x
- Revenue Growth %
- 15.85%
- Operating Profit Growth %
- -6.26%
- Net Profit Growth %
- -123.54%
- -100.41%
- P/E (x)
- 0.00x
- P/B (x)
- 5.32x
- Dividend Yield %
- 0.00%
- 46.81x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-19 - Nephrocare Health Services Limited has informed the Exchange about Transcript
- Agreements
2026-08-17 - Nephrocare Health Services Limited has informed the Exchange about Agreements
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026